Durvalumab-Associated Pneumonitis in Patients with Locally Advanced Non-Small Cell Lung Cancer: A Real-World Population Study

The PACIFIC trial led to a new standard of care for patients with locally advanced lung cancer, but real-world practice has demonstrated that immune checkpoint inhibitor (ICI) pneumonitis can lead to significant clinical complications. This study aimed to examine the clinical predictors, outcomes, a...

Cijeli opis

Bibliografski detalji

Glavni autori:	Chloe Ahryung Lim, Sunita Ghosh, Hali Morrison, Daniel Meyers, Igor Stukalin, Marc Kerba, Desiree Hao, Aliyah Pabani
Format:	Artigo
Jezik:	Inglês
Izdano:	MDPI AG 2023-12-01
Serija:	Current Oncology
Teme:	durvalumab-associated pneumonitis immunotherapy toxicity radiation pneumonitis
Online pristup:	https://www.mdpi.com/1718-7729/30/12/757
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!